Heterozygous inhibition in prion infection: the stone fence model

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• The human prion protein gene (PRNP) exhibits polymorphism at codons 129 (methionine/valine) and 219 (glutamate/lysine).
• PRNP heterozygotes appear to have a protective effect against sporadic Creutzfeldt-Jakob disease (CJD) compared to homozygotes.
• The underlying molecular mechanisms for this protective heterozygote effect remain largely unknown.

Purpose of the Study:

• To review and explain the observed inhibition of prion protein (PrP) conversion in PRNP heterozygous animal models.
• To elucidate the molecular basis for the protective effects of PRNP heterozygosity against prion diseases.
• To propose a novel mechanism, the 'stone fence model,' to explain heterozygous inhibition.

Main Methods:

• Analysis of transmission studies using PRNP heterozygous animal models.
• Investigation of PrP conversion dynamics in mice with different PRNP genotypes (129M/V and 219E/K).
• Comparative assessment of conversion competence and inhibitory effects of various PrP polymorphic forms.

Main Results:

• In 129M/V heterozygous mice infected with vCJD, the conversion-incompetent PrP 129V variant inhibited the conversion of the PrP 129M variant.
• In 219E/K heterozygous animals, both conversion-competent PrP 219E and PrP 219K variants exhibited an inhibitory effect on PrP conversion.
• These findings demonstrate a consistent inhibitory phenomenon in heterozygous PRNP contexts.

Conclusions:

• PRNP heterozygosity confers protection against prion diseases through an inhibitory mechanism on PrP conversion.
• The 'stone fence model' is proposed to explain how differing PrP polymorphic forms in heterozygotes impede prion propagation.
• Understanding this mechanism could offer new insights into prion disease pathogenesis and potential therapeutic strategies.